MedTrace Logo

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

NCT00483171 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 699

Last updated 2012-11-07

No results posted yet for this study

Summary

The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.

Conditions

Interventions

DRUG

CP-945,598

CP-945,598

BEHAVIORAL

Non-pharmacological weight loss program (NPP)

Nutrition counseling, exercise monitoring and behavioral management will occur for all arms during the NPP.

BEHAVIORAL

Low Calorie Diet

Low calorie diet

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • United States
  • Australia
  • Denmark
  • Netherlands
  • South Africa

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483171 on ClinicalTrials.gov